PMV Pharmaceuticals Inc (PMVP)
1.715
+0.02
(+1.48%)
USD |
NASDAQ |
Apr 25, 16:00
1.715
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Free Cash Flow (Quarterly): -12.28M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.28M |
| September 30, 2023 | -15.70M |
| June 30, 2023 | -13.47M |
| March 31, 2023 | -15.17M |
| December 31, 2022 | -16.96M |
| September 30, 2022 | -18.81M |
| June 30, 2022 | -17.18M |
| March 31, 2022 | -18.79M |
| Date | Value |
|---|---|
| December 31, 2021 | -12.29M |
| September 30, 2021 | -12.90M |
| June 30, 2021 | -9.707M |
| March 31, 2021 | -13.02M |
| December 31, 2020 | -10.37M |
| September 30, 2020 | -7.433M |
| June 30, 2020 | -6.896M |
| March 31, 2020 | -8.189M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-18.81M
Minimum
Sep 2022
-6.896M
Maximum
Jun 2020
-13.07M
Average
-12.96M
Median
Free Cash Flow (Quarterly) Benchmarks
| Exelixis Inc | -2.564M |
| Geron Corp | -41.00M |
| Verastem Inc | -29.68M |
| Karyopharm Therapeutics Inc | -18.58M |
| Kura Oncology Inc | -34.32M |